Form 4: CareDx Executive Sells Shares Under Pre-Arranged Trading Plan

CareDx's Secretary and General Counsel, Jeffrey Adam Novack, sold 1,917 shares of common stock at $26 per share under a pre-arranged 10b5-1 trading plan.

Summary

• Jeffrey Adam Novack, Secretary and General Counsel of CareDx, Inc., sold 1,917 shares of the company's common stock on December 4, 2024.
• The shares were sold at a price of $26 per share.
• This transaction was executed under a pre-arranged Rule 10b5-1 trading plan adopted on August 19, 2024.
• Following the transaction, Mr. Novack directly owns 110,237 shares of CareDx common stock.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing related to an executive's stock sale under a pre-arranged plan. It doesn't indicate any positive or negative sentiment towards the company's performance.

Risks

• Executive stock sales can sometimes be perceived negatively by the market, potentially impacting investor sentiment.

Industry Context

This is a routine filing related to insider trading activity and is common for publicly traded companies. It does not indicate any specific trend in the industry.

Comparison to Industry Standards

• Rule 10b5-1 trading plans are a common practice among executives of publicly traded companies to avoid accusations of insider trading.
• The sale of shares by an executive is a normal occurrence and does not necessarily indicate a negative outlook for the company.

Stakeholder Impact

• The sale of shares by an executive may have a minor impact on shareholder sentiment.

Key Dates

Keywords

CareDx, stock sale, insider trading, Form 4, Jeffrey Adam Novack, Rule 10b5-1, CDNA, executive